从心声压力/体积循环模型的逆重塑对心脏衰竭患者治疗sacubitril/Valsartan治疗的好处的见解
Frank L Dini1, Giovanni Cioffi2, Erberto Carluccio3
1Istituto Auxologico Italiano I.R.C.C.S. Milano, Italy.
The American journal of cardiology
|June 22, 2025
概括
萨库比特里尔/瓦尔萨坦治疗改善了心脏衰竭患者的腹腔动脉合和LV效率. 左心室逆向重塑与这些积极变化有关.
科学领域:
- 心脏病学 心脏病学
- 心血管生理学心血管生理学
- 心脏衰竭研究研究
背景情况:
- 左心室逆转型改造 (LVRR) 是心力衰竭的积极适应,减少喷射率 (HFrEF).
- 神经激素激活和血液动力过载有助于HFrEF的进展.
- 针对这些途径的干预措施可以诱导LVRR.
研究的目的:
- 为了研究LVRR和S/V治疗后心室 - 动脉 (VA) 合的变化之间的关系.
- 在HFrEF患者中评估与LVRR相关的机能参数的修改.
主要方法:
- 一项多中心研究涉及662名HFrEF患者 (LV EF ≤40%) 接受S/V治疗.
- 从心声回声和血压测量得出的非侵入性压力-体积循环.
- 估计动脉弹性 (Ea),LV弹性 (Ees),Ea/Ees比率,中风工作 (SW),潜在能量 (PE),PVA面积和LV效率.
主要成果:
- 14%的患者在平均7.8个月内实现了LVRR (LVEF增加>10%,LV末缩体积下降>15%).
- 患有LVRR的患者表现出改善的VA合 (Ea/Ees比率下降了45%) 和提高LV效率 (增长了24%).
- 在LVRR患者中,潜在能量 (PE) 显著下降 (-35%).
结论:
- 用S/V治疗的HFrEF患者的LVRR与改善的VA合有关.
- 增强的VA合可能有助于观察到的LV效率的改善.
- 这些发现凸显了VA合在评估HFrEF治疗反应中的重要性.
更多相关视频
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
524
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
524
01:30Heart Failure V: Medical Management
34
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
34
01:22Heart Failure Drugs: Diuretics
505
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
505
01:29Heart Failure II: Pathophysiology
59
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
59
01:25Aortic Regurgitation III: Medical Management
53
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
53